Biogen in the news
ShareCopied to clipboardAnalyze the latest Biogen news, with a current neutral sentiment polarity (-0.05) or the entire set.
Latest news
Here are the latest news on this scope:
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Ozempic hits booze sales, Moderna likes AI, and Biogen's blockbuster drug: Pharma news roundup
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Biogen dumps dubious Alzheimer's drug after profit-killing FDA scandal
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Biogen to shut down its controversial Alzheimer's drug Aduhelm
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time